dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Sissetulev dokumentAvalik

Kiri

Terviseamet · 13. november 2024
Viit
11.1-2/24/11717-1
Registreeritud
13. november 2024
Dokumendi liik
Sissetulev dokument
Adressaat
Advena
Saabumis/saatmisviis
e-post
Funktsioon
11.1 SULETUD 2025 Turustamise järgne järelevalve (post-marketing surveillance)
Sari
11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
Toimik
11.1-2/2023
Vastutaja
Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)

Failid

  • 📎FW_ Medical Device Notification Prior to Placing Medical Device on the Market.msg124 KB

Sisu (failidest)

Saatja: Ravimiamet </O=SOTSIAALMINISTEERIUM/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=RAVIMIAMET8B2> Saaja: Meditsiiniseadmed (Medical Devices) Teema: FW: Medical Device Notification Prior to Placing Medical Device on the Market Tere Edastan e-kirja. Heade soovidega Kärolin Jenas Ravimiamet üldosakonna dokumendihalduse spetsialist Telefon 737 4140 [email protected]<mailto:[email protected]> Nooruse 1 50411 Tartu www.ravimiamet.ee<http://www.ravimiamet.ee/> [logo_ravimiamet_3lovi_eesti_sinine] Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. From: Sam Attard <[email protected]> Sent: esmaspäev, 24. aprill 2023 10:44 To: Ravimiamet <[email protected]> Subject: Medical Device Notification Prior to Placing Medical Device on the Market Dear State Agency of Medicines, We trust this email finds you well. We are an authorised representative based in Malta and we represent a number of medical device manufacturers all over the world. We are aware that in some EU countries, such as Italy, the manufacturer will have to submit a notification or register their device on a national database prior to placing the medical device on the national market. Our questions are the following; * Does the manufacturer need to submit a notification prior to placing their device on the Estonian Market? * Do they still need to submit the notification if they are registered on EUDAMED? * Can the Authorized Representative submit the notification on behalf of the manufacturer? We look forward to hearing from you and taking you in advance for your time. Wishing you a fantastic week ahead. Kindest Regards, Sam Attard Regulatory Associate [cid:[email protected]]<http://www.advena.mt/> Advena. t: +356 2546 6689 e: [email protected]<mailto:[email protected]> a: Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta w: www.advena.mt<http://www.advena.mt/> Follow us on: [Logo, icon Description automatically generated] <https://www.linkedin.com/company/advena-ltd./?viewAsMember=true> [Logo Description automatically generated] <https://twitter.com/AdvenaMalta> For Regulatory Updates Subscribe to our Newsletter: [A blue sign with white text Description automatically generated with low confidence] <https://advena.us10.list-manage.com/subscribe?u=67ce44d672cae6397890ccd5b&id=fda73b3c42> IMPORTANT: This e-mail and any resulting email thread, including attachments, may contain confidential information. If you are not the intended recipient it may be unlawful for you to read, copy, distribute, disclose, or otherwise use the information contained in this e-mail. If you have received this email in error, please notify the sender by email and destroy/delete all copies immediately. Errors and omissions may occur in the contents of this e-mail arising out of or in connection with data transmission, network malfunction or failure, machine or software error or malfunction, or operator/operation error. Advena accepts no responsibility for any such errors or omissions, and you are advised to confirm the accuracy of the contents of this e-mail before relying on it for any purpose. Registered offices: Advena Ltd - Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta. Company registered in Malta: C 76865. Advena Services Ltd - Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta. Company registered in Malta: C 103067. Parent Company: Advena Malta (Holdings) Ltd - Highdown House, 11 Highdown Road, Leamington Spa, England, CV31 1XT United Kingdom. Reg No 13789474
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel